Principle Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.51M | Buy |
3,713
+476
| +15% | +$193K | 0.09% | 129 |
|
2025
Q1 | $1.61M | Buy |
3,237
+105
| +3% | +$52.2K | 0.12% | 129 |
|
2024
Q4 | $1.63M | Hold |
3,132
| – | – | 0.11% | 132 |
|
2024
Q3 | $1.94M | Buy |
3,132
+71
| +2% | +$43.9K | 0.14% | 122 |
|
2024
Q2 | $1.69M | Hold |
3,061
| – | – | 0.13% | 129 |
|
2024
Q1 | $1.78M | Buy |
3,061
+270
| +10% | +$157K | 0.14% | 126 |
|
2023
Q4 | $1.48M | Sell |
2,791
-4
| -0.1% | -$2.12K | 0.13% | 133 |
|
2023
Q3 | $1.41M | Buy |
2,795
+99
| +4% | +$50.1K | 0.14% | 126 |
|
2023
Q2 | $1.41M | Buy |
2,696
+3
| +0.1% | +$1.57K | 0.14% | 120 |
|
2023
Q1 | $1.55M | Buy |
2,693
+40
| +2% | +$23.1K | 0.17% | 110 |
|
2022
Q4 | $1.46M | Hold |
2,653
| – | – | 0.17% | 108 |
|
2022
Q3 | $1.35K | Buy |
2,653
+1
| +0% | +$1 | 0.13% | 102 |
|
2022
Q2 | $1.44M | Sell |
2,652
-158
| -6% | -$85.9K | 0.17% | 104 |
|
2022
Q1 | $1.66M | Hold |
2,810
| – | – | 0.17% | 105 |
|
2021
Q4 | $1.88M | Buy |
2,810
+15
| +0.5% | +$10K | 0.2% | 94 |
|
2021
Q3 | $1.6M | Sell |
2,795
-25
| -0.9% | -$14.3K | 0.18% | 102 |
|
2021
Q2 | $1.42M | Sell |
2,820
-248
| -8% | -$125K | 0.16% | 108 |
|
2021
Q1 | $1.4M | Hold |
3,068
| – | – | 0.16% | 106 |
|
2020
Q4 | $1.43M | Buy |
3,068
+751
| +32% | +$350K | 0.19% | 101 |
|
2020
Q3 | $1.02M | Sell |
2,317
-103
| -4% | -$45.5K | 0.29% | 52 |
|
2020
Q2 | $877K | Buy |
2,420
+19
| +0.8% | +$6.89K | 0.26% | 55 |
|
2020
Q1 | $681K | Buy |
2,401
+5
| +0.2% | +$1.42K | 0.26% | 58 |
|
2019
Q4 | $778K | Hold |
2,396
| – | – | 0.25% | 69 |
|
2019
Q3 | $698K | Sell |
2,396
-245
| -9% | -$71.4K | 0.24% | 72 |
|
2019
Q2 | $776K | Sell |
2,641
-218
| -8% | -$64.1K | 0.4% | 50 |
|
2019
Q1 | $783K | Hold |
2,859
| – | – | 0.45% | 46 |
|
2018
Q4 | $640K | Buy |
+2,859
| New | +$640K | 0.54% | 45 |
|